Mission GBM
Subscribe
Sign in
Home
Glossary of Terms
Brain Cancer News
Brain Cancer Science Talk
Clinical Trials
FAQs
Goals of Care
Investing in Brain Cancer
Julie's Journey
Meet the Team
Archive
About
Investing in Brain Cancer
Postcards from the Field
Some green shoots of investing progress as MissionGBM welcomes its 300th case
Jul 30, 2024
•
Scott L. Rakestraw, PhD
12
Investing in Brain Cancer – Part 5
Models Designed to Bridge to Institutional & Strategic Investors
Feb 13, 2024
•
Scott L. Rakestraw, PhD
2
Investing in Brain Cancer - Part 4
Patient Advocacy Groups, Foundations & Family Offices
Feb 7, 2024
•
Scott L. Rakestraw, PhD
4
Investing in Brain Cancer - Part 3b
Strategic Investor Perspective
Jan 30, 2024
•
Scott L. Rakestraw, PhD
4
Investing in Brain Cancer - Part 3a
Institutional Investor Perspective
Jan 26, 2024
•
Scott L. Rakestraw, PhD
1
28:05
Investing in Brain Cancer - Part 2
Therapeutic Strategy…with some Business & Investment Strategy sprinkled in
Jan 16, 2024
•
Scott L. Rakestraw, PhD
4
MimiVax Announces New Investments to Support Clinical Development of SurVaxM in Glioblastoma
Example of a transitional model for financing brain cancer therapeutics development
Jan 10, 2024
•
Scott L. Rakestraw, PhD
2
Investing in Brain Cancer - Part 1
Scope of the Challenge
Jan 8, 2024
•
Scott L. Rakestraw, PhD
6
Stanford's Innovative Medicines Accelerator and The Invus Group Collaborate to Attack GBM
An important and visionary partnership featuring multiple members of Team Julie
Jan 10, 2023
•
Scott L. Rakestraw, PhD
4
Can We Talk? Starting Important Conversations About Increasing Investment in Brain Cancer R&D
Multiple, independent R&D streams and major investor discussions are converging on a set of new models for accelerating brain cancer therapeutics…
Nov 29, 2022
•
Scott L. Rakestraw, PhD
5
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
